The Delhi government on Friday issued a detailed advisory to bolster Covid-19 preparedness in hospitals across the city, amid ...

On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations.  The Vaccines and Related Biological Products Advisory ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...

Vaccine advisers to the FDA decided Thursday that only strains of the JN.1 variant should be targeted by updated versions of covid vaccines that will be available next fall and winter. Separately, ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

WASHINGTON (AP) — A government report released on Thursday covering wide swaths of American health and wellness reflects some ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...